T cells for suicide gene therapy: Activation, functionality and clinical relevance

Journal of Immunological Methods

Volumn 331, Issue 1-2, 2008, Pages 69-81

  Hollatz, Gabriele ^a   Grez, M ^b   Mastaglio, S ^c   Quaritsch, R ^a   Huenecke, S ^a   Ciceri, F ^c   Bonini, C ^c   Esser, R ^a   Klingebiel, T ^a   Kreuter, J ^a   Koehl, U ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Institute for Biomedical Research   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Activation; Beads; Immune competence; Suicide gene therapy; T cells

Indexed keywords

CD3 ANTIBODY; CD4 ANTIBODY; CYTOKINE; INTERLEUKIN 2;

ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE THERAPY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SUICIDE GENE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSDUCTION, GENETIC;

EID: 39149133982     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.11.007     Document Type: Article

References (44)

1. Bader P., Kreyenberg H., Hoelle W., Dueckers G., Handgretinger R., Lang P., Kremens B., Dilloo D., Sykora K.W., Schrappe M., Niemeyer C., Von Stackelberg A., Gruhn B., Henze G., Greil J., Niethammer D., Dietz K., Beck J.F., and Klingebiel T. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?. J. Clin. Oncol. 22 (2004) 1696
2. Becker P.S. The current status of gene therapy in autologous transplantation. Acta Haematol. 114 (2005) 188
3. Bisset L.R., Lung T.L., Kaelin M., Ludwig E., and Dubs R.W. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur. J. Haematol. 72 (2004) 203
4. Bochennek K., Andreas C., Margraf C., Stahlkamp H., Zimmermann S., Esser R., Schwabe D., Klingebiel T., Gruttner H.P., and Koehl U. Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients. Bone Marrow Transplant. 36 (2005) 481
5. Bondanza A., Valtolina V., Magnani Z., Ponzoni M., Fleischhauer K., Bonyhadi M., Traversari C., Sanvito F., Toma S., Radrizzani M., La Seta-Catamancio S., Ciceri F., Bordignon C., and Bonini C. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107 (2006) 1828
6. Bonini C., Ferrari G., Verzeletti S., Servida P., Zappone E., Ruggieri L., Ponzoni M., Rossini S., Mavilio F., Traversari C., and Bordignon C. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276 (1997) 1719
7. Burt R.K., Drobyski W.R., Seregina T., Traynor A., Oyama Y., Keever-Taylor C., Stefka J., Kuzel T.M., Brush M., Rodriquez J., Burns W., Tennant L., and Link C. Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions. Exp. Hematol. 31 (2003) 903
8. Burt R.K., Drobyski W.R., Traynor A.E., and Link Jr. C.J. Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes. Bone Marrow Transplant. 24 (1999) 1043
9. Ciceri F., Bonini C., Marktel S., Zappone E., Servida P., Bernardi M., Pescarollo A., Bondanza A., Peccatori J., Rossini S., Magnani Z., Salomoni M., Benati C., Ponzoni M., Callegaro L., Corradini P., Bregni M., Traversari C., and Bordignon C. Anti-tumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem cell transplantation. Blood 109 (2007) 4698
10. Cohen J.L., and Salomon B.L. Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation. Cytotherapy 7 (2005) 166
11. Contassot E., Murphy W., Angonin R., Pavy J.J., Bittencourt M.C., Robinet E., Reynolds C.W., Cahn J.Y., Herve P., and Tiberghien P. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation 65 (1998) 1365
12. Dazzi F., and Goldman J.M. Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu. Rev. Med. 49 (1998) 329
13. Drobyski W.R., Majewski D., Ozker K., and Hanson G. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. J. Immunol. 161 (1998) 2610
14. Fehse B., Kustikova O.S., Li Z., Wahlers A., Bohn W., Beyer W.R., Chalmers D., Tiberghien P., Kuhlcke K., Zander A.R., and Baum C. A novel 'sort-suicide' fusion gene vector for T cell manipulation. Gene Ther. 9 (2002) 1633
15. Ferrand C., Robinet E., Contassot E., Certoux J.M., Lim A., Herve P., and Tiberghien P. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum. Gene Ther. 11 (2000) 1151
16. Giralt S., Khouri I., and Champlin R. Non myeloablative "mini transplants". Cancer Treat. Res. 101 (1999) 97
17. Hoffmann P., Ermann J., and Edinger M. CD4+CD25+ regulatory T cells in hematopoietic stem cell transplantation. Curr. Top. Microbiol. Immunol. 293 (2005) 265
18. Junker K., Koehl U., Zimmerman S., Stein S., Schwabe D., Klingebiel T., and Grez M. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther. 10 (2003) 1189
19. Kalamasz D., Long S.A., Taniguchi R., Buckner J.H., Berenson R.J., and Bonyhadi M. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies. J. Immunother. 27 (2004) 405
20. Klingemann H.G., and Martinson J. Ex vivo expansion of natural killer cells for clinical applications. Cytotherapy 6 (2004) 15
21. Koehl U., Bochennek K., Zimmermann S.Y., Lehrnbecher T., Sorensen J., Esser R., Andreas C., Kramm C., Gruttner H.P., Falkenberg E., Orth A., Bader P., Schwabe D., and Klingebiel T. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival. Bone Marrow Transplant. 39 (2007) 269
22. Lamana M.L., Bueren J.A., Vicario J.L., and Balas A. Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer. Gene Ther. 11 (2004) 474
23. Lan F., Zeng D., Higuchi M., Higgins J.P., and Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant. 9 (2003) 355
24. Lan F., Zeng D., Higuchi M., Huie P., Higgins J.P., and Strober S. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol. 167 (2001) 2087
25. Link Jr. C.J., Burt R.K., Traynor A.E., Drobyski W.R., Seregina T., Levy J.P., Gordon L., Rosen S.T., Burns W.H., Camitta B., Casper J., Horowitz M., Juckett M., Lawton C., Margolis D., Pietryga D., Rowlings P., Taylor C., Furtado M., Stefka J., Gupta-Burt S., Kaiser H., and Vesole D.H. Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. Hum. Gene Ther. 9 (1998) 115
26. Link Jr. C.J., Traynor A., Seregina T., and Burt R.K. Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene. Cancer Treat. Res. 101 (1999) 369
27. Marijt W.A., and Falkenburg J.H. Specific T cell therapy in leukemia. J. Hematother. Stem Cell Res. 10 (2001) 493
28. Marktel S., Magnani Z., Ciceri F., Cazzaniga S., Riddell S.R., Traversari C., Bordignon C., and Bonini C. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101 (2003) 1290
29. Mutis T., Aarts-Riemens T., and Verdonck L.F. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. Haematologica 90 (2005) 1389
30. Orchard P.J., Blazar B.R., Burger S., Levine B., Basso L., Nelson D.M., Gordon K., McIvor R.S., Wagner J.E., and Miller J.S. Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor. Hum. Gene Ther. 13 (2002) 979
31. Qasim W., King D., Buddle J., Verfuerth S., Kinnon C., Thrasher A.J., and Gaspar H.B. The impact of retroviral suicide gene transduction procedures on T cells. Br. J. Haematol. 123 (2003) 712
32. Recchia A., Bonini C., Magnani Z., Urbinati F., Sartori D., Muraro S., Tagliafico E., Bondanza A., Stanghellini M.T., Bernardi M., Pescarollo A., Ciceri F., Bordignon C., and Mavilio F. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc. Natl. Acad. Sci. USA 103 (2006) 1457
33. Sauce D., Bodinier M., Garin M., Petracca B., Tonnelier N., Duperrier A., Melo J.V., Apperley J.F., Ferrand C., Herve P., Lang F., Tiberghien P., and Robinet E. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 99 (2002) 1165
34. Sauce D., Rufer N., Mercier P., Bodinier M., Remy-Martin J.P., Duperrier A., Ferrand C., Herve P., Romero P., Lang F., Tiberghien P., and Robinet E. Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells. Blood 102 (2003) 1241
35. Sauce D., Tonnelier N., Duperrier A., Petracca B., de Carvalho Bittencourt M., Saadi M., Saas P., Ferrand C., Herve P., Tiberghien P., and Robinet E. Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J. Hematother. Stem Cell Res. 11 (2002) 929
36. Schetelig J., Kiani A., Schmitz M., Ehninger G., and Bornhauser M. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol. Immunother. 54 (2005) 1043
37. Tiberghien P., Cahn J.Y., Brion A., Deconinck E., Racadot E., Herve P., Milpied N., Lioure B., Gluckman E., Bordigoni P., Jacob W., Chiang Y., Marcus S., Reynolds C., and Longo D. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study. Hum. Gene Ther. 8 (1997) 615
38. Tiberghien P., Ferrand C., Lioure B., Milpied N., Angonin R., Deconinck E., Certoux J.M., Robinet E., Saas P., Petracca B., Juttner C., Reynolds C.W., Longo D.L., Herve P., and Cahn J.Y. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97 (2001) 63
39. Traversari C., Marktel S., Magnani Z., Mangia P., Russo V., Ciceri F., Bonini C., and Bordignon C. The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. Blood 109 (2007) 4708
40. Trickett A., and Kwan Y.L. T cell stimulation and expansion using anti-CD3/CD28 beads. J. Immunol. Methods 275 (2003) 251
41. Weijtens M., van Spronsen A., Hagenbeek A., Braakman E., and Martens A. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Hum. Gene Ther. 13 (2002) 187
42. Williams D.A., and Baum C. Medicine. Gene therapy-new challenges ahead. Science 302 (2003) 400
43. Yu K.O., and Porcelli S.A. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100 (2005) 42
44. Zeng D., Lewis D., Dejbakhsh-Jones S., Lan F., Garcia-Ojeda M., Sibley R., and Strober S. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189 (1999) 1073